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Abstract Vascular and cardiac disease remains a
leading cause of morbidity and mortality in developed
and emerging countries. Vascular and cardiac inter-
ventions require extensive fluoroscopic guidance to
navigate endovascular catheters. X-ray fluoroscopy is
considered the current modality for real time imaging.
It provides excellent spatial and temporal resolution,
but is limited by exposure of patients and staff to
ionizing radiation, poor soft tissue characterization and
lack of quantitative physiologic information. MR
fluoroscopy has been introduced with substantial
progress during the last decade. Clinical and experi-
mental studies performed under MR fluoroscopy have
indicated the suitability of this modality for: delivery
of ASD closure, aortic valves, and endovascular stents
(aortic, carotid, iliac, renal arteries, inferior vena cava).
It aids in performing ablation, creation of hepatic
shunts and local delivery of therapies. Development of
more MR compatible equipment and devices will
widen the applications of MR-guided procedures. At
post-intervention, MR imaging aids in assessing the
efficacy of therapies, success of interventions. It also
provides information on vascular flow and cardiac
morphology, function, perfusion and viability. MR
fluoroscopy has the potential to form the basis for
minimally invasive image–guided surgeries that offer
improved patient management and cost effectiveness.
Keywords Cardiac imaging 
Magnetic resonance imaging  Vascular imaging
Introduction
The rapid evolution of minimally invasive vascular
and cardiac interventions is shaping the demand for
high temporal and spatial resolution imaging that
offers safety, accuracy, flexibility and functionality.
Recent improvements in signal processing, tissue
characterization and angiographic integration allowed
MR-guidance in complex interventional procedures,
which require optimal spatial resolution and orienta-
tion [1, 2]. MR fluoroscopy offers rapid acquisition,
reconstruction and display of 3D images. Therefore, it
has been used in biopsies [3–7], brachytherapy [8, 9],
focused ultrasound [10–13], thermometry [10, 14–17],
functional imaging integrated into MR guided neuro-
surgical interventions [18, 19], local drug delivery
[20, 21], endoscopy [22], intravascular interventions
[23–34] and intra-operative imaging [19, 35–40].
X-ray fluoroscopy
X-ray fluoroscopy is routinely used in patients to
guide vascular and cardiac interventions, because of
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its ability for real-time imaging and easy access to
patients during interventions [41–43]. X-ray fluoros-
copy, however, is limited for defining soft tissue and
obtaining functional information. The poor contrast
between pathologic and healthy surrounding tissue
hinders X-ray fluoroscopy in defining targets [44],
which subsequently leads to blind delivery of ther-
apies to the targets [20, 45]. Furthermore, there is a
growing body of evidence that exposure to ionizing
radiation from X-ray procedures is associated with an
increased risk of cancer [46–50].
Interventional MR magnets
Different MR magnet designs have been developed,
namely open and hybrid, for MR guided vascular and
cardiac interventions [51]. Open magnets were
designed to ease patient access. Both open and
double donut XMR hybrid magnets use 0.2T and
0.5T fields and have low gradient strength. These low
field magnets offer suboptimal image quality and
slow switching speeds that do not meet the need of
cardiovascular interventions. For example, Wacker
et al. [52] found that 1.0T closed-bore halved the
procedure time during stent deployment compared to
0.2T open-bore magnet. Another hybrid XMR system
consists of an angiographic laboratory adjacent to
closed-bore 1.5T MR magnet, wherein an on-track
patient table could be moved rapidly between the two
imaging modalities (Fig. 1a) [53, 54]. More recently,
another XMR hybrid system has been developed that
has a side-by-side 1.5T magnet and C-arm X-ray
system (Personal communication) (Fig. 1b). The
in-suite operation consoles and display monitors are
of great help in instant imaging acquisition and
monitoring.
The advantages of hybrid XMR systems are: (1)
intermodal movement is minimized because a patient
will remain on a sliding table throughout the imaging
session; (2) unlike single system, the XMR hybrid
system permits evaluation of the impact of interven-
tional procedures via MR monitoring; (3) it permits
rapid deployment of catheters, and efficient execution
of desired interventions without the obligation of
using MR compatible devices; (4) it reduces radiation
exposure [55] and (5) offers the convenience of a
single visit. However, currently XMR systems are
available only in few medical centers.
Devices for MR interventions
Unfortunately, endovascular catheters and devices
are optimized for their mechanical properties and
visibility under projection X-ray imaging. There are,
therefore, substantial metallic components within the
plastic sheath that may be ferrous in nature. Visual-
ization of these commercial endovascular catheters
and devices has been difficult on MR imaging due to
the susceptibility artifacts derived from the ferro-
magnetic material, geometry and design [56, 57].
Unlike ferromagnetic material, nickel-titanium alloy
(nitinol), platinum, gold, copper, nonbraided or
plastic catheters cause substantially less susceptibility
artifacts [57–59] and produce less radiofrequency
Fig. 1 Two types of hybrid XMR suites equipped with a
closed bore 1.5T MR magnet and C-arm X-ray fluoroscopy.
The a suite consists of 2 rooms separated by a sliding door
(Phillips Medical Systems). The recently developed hybrid
system b is an example of a more advanced facility, where both
C-arm X-ray fluoroscopy and 1.5T MR systems are in the same
room, thereby making interventional procedures shorter and
more efficient (courtesy of Dr. Graham Wright, Sunnybrook,
Toronto)
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heating in vivo [60, 61]. Nitinol stents and guide-
wires are currently used for revascularization of
stenosed blood vessels. Mekle et al. [62, 63] used a
synthetic MR friendly polymer-based guide-wire for
dilatation of an artificial stenosis in phantoms and in
the carotid artery, aorta, and iliac arteries of swine
[63]. More recently, investigators manufactured a
guide wire based on micropultruded fiber-reinforced
material doped with iron particles to improve visibility.
At the distal part of the guide-wire a nitinol wire was
attached to provide flexibility to the tip [64].
In vitro studies showed that MR fluoroscopy can
track and navigate nitinol catheters (Fig. 2). At the
present time, few prototype catheters have been
designed [21, 65–67], but require further investiga-
tion. The catheters used for local drug delivery under
MR fluoroscopy contain a steering device and needle-
adjusting scale pistol at one end and a nitinol needle,
which is a part of a thin nitinol catheter runs inside
the catheter at the other end.
Investigators used three approaches for endovas-
cular catheter tracking and navigation, namely pas-
sive tracking (Fig. 3), active tracking (Figs. 2, 3) and
magnetic catheter steering (Fig. 4). Investigators also
used dysprosium markers mounted on 3F non-braided
catheters for tracking and visualizing the catheters.
The contrast between the catheter and background
blood can be improved by injecting MR contrast
media, which prevents flow artifacts because the
steady state is reached earlier [54, 68]. Bakker et al.
[24] were the first to use the passive tracking
approach for steering basilica veins of healthy
volunteers. Later, this passive approach was adapted
by Manke et al. [69] and Razavi et al. in patients [70].
The advantage of this technique is that it requires no
hardware or instrument modifications and, thus,
appears to be particularly promising in terms of
potential clinical applications. The disadvantage is
that the catheter disappears when it is out of the
image plane due to the motion.
Active tracking is another approach for tracking
endovascular catheters (Figs. 2, 3). This technique
relies on specially designed micro-coils, electrified
wire loop and self-resonant radiofrequency circuits.
The coils pick up signal during slice excitation and
generate a frequency-encoded recall echo, which can
be detected in 3D at a spatial resolution of approx-
imately 1 mm. The micro coils provide robust
tracking of the catheter shaft and tip that allows the
user to identify its position and target (Fig. 3) [71–
74]. Quick et al. [75] used antennas for active
catheter tracking and imaging of the abdominal aorta,
superior mesenteric artery, renal arteries, hepatic
artery and celiac trunk. In another study, they were
able to simultaneously visualize vascular tree, cath-
eter shaft and tip [76]. The advantage of this
technique is that it allows for visualization of longer
portion of the catheter or guidewire when a loopless
antenna is placed. On the other hand, the disadvan-
tage includes the need for special hardware and
software. Furthermore, the support patient systems,
interventional devices and surgical instruments must
be MR-compatible. MR-compatible equipment for
anesthesia, assessment of physiologic parameters and
contrast media injection are currently offered by
multiple venders.
Fig. 2 MR images show the activated coils in a water bath.
a Shows the external surface coil elements, b a coil placed on
the shaft of the catheter and c a coil placed at the catheter tip.
This type of active catheter has been frequently used for
transendocardial delivery of stem cells and angiogenic genes
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Fig. 3 Selected MR fluoroscopic images show the passive a,
b and active c, d catheters in the left ventricle hitting
myocardial targets (arrows). The passive catheter is labeled
with MR contrast media, while the active catheter wrapped
with coil. Note that the background anatomy of the heart and
great vessels can be clearly visualized using both the active
catheter and active body coil (d)
Fig. 4 Dynamic coronal MR images of a 2.5F two axis
(saddle and helical) coil-tipped catheter deflected and
advanced up the left (a, b) and right c, d of a phantom (B0-
Bore of magnet). The in vivo study shows the catheter in the
superior mesenteric artery (red arrows, e, f)
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The safety of active endovascular devices is still a
major concern. The conductive nature of the long
metallic braid creates a safety hazard in the MR
environment, as the braided shaft can interact with
incident RF energy and the electric field transmitted
from the RF coil [60, 61, 77]. The heat created by the
active coils causes necrosis of the tissue adjacent to
the catheter and blood clotting, which may lead to
vascular embolization. The methods for mitigating
the potential for heating include using unbraided
catheters, insulating the conductive structure, limiting
the RF power to which it is exposed, or altering its
interaction with the RF energy source [78]. The FDA
limits the allowable power deposition via MR
imaging to 8 W/kg and temperature change to 2C.
Patients with internalized devices containing long
conductive structures, such as deep brain stimulators
[79] and cardiac pacemakers [80–82], are presently
scanned with MR imaging provided additional safety
steps are taken. These typically include heightened
patient monitoring, lower permissible specific absorp-
tion rate levels, and the use of local transmit RF coils.
Magnetic catheter steering is a new approach for
tracking endovascular catheters using remote control
[83]. It relies on a small magnetic moment created by
application of an electrical current to copper coils on
the catheter tip, which results in alignment of the
catheter in the direction of the B0 field (Fig. 4) [84,
85]. Magnetic catheter steering approach allows for
more efficiency in navigating small, tortuous blood
vessels, which are currently difficult to catheterize
due to build-up of friction at vascular bends. In
addition to improved visualization of the endovascu-
lar catheter at low power levels, this technology
permits deposition of thermal energy for ablation of
tissues at higher power levels. This technology is
under active investigation [86, 87].
MR contrast media
MR fluoroscopy and catheter tracking can be
expanded using a variety of MR contrast media with
high safety profiles [88–90]. Investigators used
extracellular and intravascular MR contrast media
with T1-enhancing or T2-enhancing capabilities for
labeling different types of cells [91, 92]. Extracellular
MR contrast media have small molecular weights
(\1 kDa), brief plasma half-life and are clinically
used in vascular angiography and in assessing
myocardial viability. On the other hand, intravascular
(blood pool) MR contrast media have high molecular
weights ([50 kDa), mass and T1 relaxivity with
prolonged plasma half-life. Preclinical experiments
showed that intravascular contrast media provide
better vascular angiograms. Moreover, contrast media
have been used on MR fluoroscopy to improve
visualization of endovascular devices [20], in road
mapping blood vessels [93, 94] and defining patho-
logic targets [95]. Investigators also used MR
contrast media for labeling different types of cells
[91, 92], which assist in monitoring the distribution of
the injected cells in vivo [96–98].
A study showed that high dose or repeated admin-
istration of gadolinium might be a concern, especially
in patients with impaired renal function [99]. This
problem can be reduced by paying attention to a
glomerular filtration rate of[30 ml/min/1.73 m2 and
contrast agents with high molecular stability [100].
MR fluoroscopy sequences
MR fluoroscopy became possible because of the
major advancements in the speed of data acquisition,
data transfer, and interactive control and display.
Other factors include highly uniform magnetic fields,
rapidly changeable magnetic field gradients, multi-
channel receivers and computing systems. MR fluo-
roscopy sequences achieve their high speeds by
maximizing the switching rates of gradients and RF
pulses. The temporal and spatial resolution in MR
fluoroscopy are often complementary factors. The
speed of imaging is determined by how quickly
spatial encoding can be performed and how fast
k-space data can be acquired. Actively shielded,
strong, fast-switching gradients and fast electronics
have allowed data acquisition intervals to be reduced.
Fast MR imaging techniques have been developed
in recent years, allowing frame rates almost compa-
rable to those achieved with X-ray fluoroscopy. Most
modern real-time MR implementations employ bal-
anced steady state free precession techniques because
of efficient use of magnetization, high SNR, and short
repetition times [101–103]. The performance of these
sequences is currently in the range needed to perform
MR guided procedures at [5 fps [104]. The SSFP
acquisitions have been performed using radial [105],
and spiral [106] k-space trajectories. These acquisition
techniques in conjunction with spiral or radial filling of
Int J Cardiovasc Imaging (2012) 28:117–137 121
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the k-space are considered very reliable for high
spatial and temporal resolutions. These imaging
sequences also benefit from the use of multiple
receiver coil elements [107–109]. Parallel imaging
accelerates acquisition by using the different spatial
sensitivities of the coils to correct for under-sampling
of image data [110]. Other sequences that can improve
imaging speed while simultaneously balancing imag-
ing quality include non-Cartesian k-space sampling,
temporal data sharing between images, and adjusting
the tradeoff between temporal and spatial resolution
[102]. The use of 32 channel receiver arrays that will
perform rapid 3D cardiac imaging and parallel trans-
mission techniques to permit more efficient parallel
data collection are also under active investigation
[111]. It should be noted that MR fluoroscopy is not
free of limitations. For example, the closed configu-
ration of MR magnets[1.5T limit access to the patient
and RF pulses induce heating when conductive
material is applied in devices; MR imaging has
relatively low spatial and temporal resolution com-
pared with X-ray fluoroscopy; and is sensitive to
magnetic field inhomogeneity, pulsatility and motion
of spins and chemical shift.
In pre and post-intervention the following MR
sequences were used: (a) balanced fast field echo CINE
images for measuring LV volumes, ejection fraction,
cardiac output, stroke volume, LV mass, wall thickness
and radial strain [90, 112–114], (b) tagged gradient
echo planar imaging for measuring circumferential
strain and LV rotation [115, 116], (c) phase-contrast
velocity-encoded gradient echo planar imaging for
measuring longitudinal strain [117], (d) T2-weighted
turbo spin echo sequence for measuring interstitial
edema after ablation, (e) T2* multi-echo gradient echo
sequence for measuring vascular and myocardial
hemorrhage after intervention [118], (f) T1-weighted
gradient echo (radiofrequency spoiled) perfusion
imaging sequence for measuring myocardial perfusion
changes after delivery of therapy, and (g) delayed
contrast enhanced 3D T1-weighted gradient echo
sequence for assessing tissue viability.
Applications of MR fluoroscopy
Vascular interventions
MR imaging provides detailed information on vas-
cular layers and is able to differentiate between
plaque components, such as fibrous, lipid rich and
calcified tissue [119, 120]. In the last decade MR
imaging has been extended from a diagnostic to a
dynamic modality, which can be used to guide
intravascular guidewires and catheters and to assess
the success of endovascular procedures. In 1997 the
first human MR-guided study was performed and
showed excellent visualization of an endovascular
catheter labeled with dysprosium ring markers [24].
In this study, investigators did not use guide wires
during the movement of the catheter in the cephalic
vein of healthy volunteers. Later, MR-guided percu-
taneous transluminal angioplasty has been conducted
without complications in 13 patients with iliac
stenosis [121] and in 15 patients with femoral and
popliteal artery stenosis [122].
MR-guided procedures (stenting and/or angio-
plasty) have been performed for dilatation of the
aorta, pulmonary, coronary, renal iliac and femoral
arteries [45, 57, 121–124]. MR-guided imaging has
been used for delivery of stents in major and minor
blood vessels [45, 52, 57, 125–131]. Vascular stents,
vena cava filters, cardioseptal occluders or prosthetic
heart valves require, however, post-interventional
follow-up, which are usually made under X-ray or
CT. MR imaging, with its superior soft-tissue
contrast, arbitrary slice orientation and flow mea-
surement would be the preferred imaging technique;
however, most conventional vascular implants made
of metal create image artifacts and masked visuali-
zation of the lumen. The three main types of MR
artifacts associated with metallic vascular implants
are susceptibility artifacts, flow-related artifacts and
RF artifacts. Active MR resonant stents provide non-
invasive visualization of instant thrombosis and
restenosis without the need for MR contrast media.
Visualization of the lumen of vascular implants is
important for a safe and reliable examination on MR-
guided procedures.
Mahnken et al. used MR-guided procedures for
placement of aortic stents grafts [132]. More recently,
Kos et al. used a polyetheretherketone-based MR
imaging-compatible guidewire in swine for aortic
stenting and vena cava filter placement [133]. Several
groups have successfully used MR-guidance for
placement of vena cava filters [134, 135]. Pulmonary
artery stents have also been accurately implanted
across the pulmonary valve [57, 58, 136]. It should be
noted that only a few investigators have performed
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vascular stenting in patients under MR guidance
[121, 122]. Manke et al. [121] successfully deployed
stents under MR-guidance in iliac arterial stenosis in
patients. Post-interventional MR imaging showed the
localization and function of the stents. MR fluoros-
copy has been recently used for assessment of the
pulmonary arterial pressure in pediatric and adult
patients with congenital heart disease [70, 137]. A
variety of MR-guided interventions have been per-
formed in patients with congenital heart diseases
including; placing transjugular, intrahepatic porto-
systemic stents, radiofrequency ablation, aortic coarc-
tation, atrio-septal defect (Fig. 5) and cardiac
catheterization. In 2006, Krueger et al. performed
the first MR-guided study using balloon angioplasty
for treating aortic coarctation in 5 patients. This was
an important step toward MR-guided treatment of this
congenital disease [138].
Kuehne et al. [139] demonstrated successful
implant of a self-expanding stent valve in the aorta
via percutaneous access under MR fluoroscopy.
Transcatheter aortic valve implantation, either retro-
grade through a transfemoral approach or antegrade
through a transapical approach, has become a clinical
reality in the treatment of critical aortic stenosis in
high-risk patients. MR fluoroscopy plays an impor-
tant role in transcatheter aortic valve implantation
and replacement of insufficient aortic or pulmonic
valves [57, 58, 136]. MR imaging enables accurate
and reproducible quantifications of regurgitate
fraction before and after valve placement. Under
MR fluoroscopy, McVeigh et al. [140] used apical
access to guide the placement of a prosthetic aortic
valve in beating heart. MR imaging offered the
visualization of both coronary ostium during stent
implantation and allowed aortic flow assessment.
Cardiac interventions
Percutaneous closure of atrio-septal defects and ven-
triculo-septal defects is increasingly performed under
X-ray, which brings the disadvantages of ionizing
radiation and lack of soft-tissue contrast. MR imaging
is a technique that provides high-resolution 3D images
of the heart. Three-dimensional MR imaging before
intervention is particularly important because it
improves our understanding of the anatomic basis of
complex arrhythmias. Closure of such congenital
defects under MR-guidance has been proved in
animals [141], but is hampered by image artifacts
produced by the materials of the closure devices and
the use of fast sequences for cardiac imaging [142].
Few studies showed that MR imaging is useful for
arrhythmic substrate identification [143, 144].
MR-guided procedures have been successfully
used in thermal ablation and after intervention to
assess the success of ablation [145–150]. Clinical
studies showed atrial scar on contrast enhanced MR
imaging that results from RF ablation [151–153].
Other studies have demonstrated the association
Fig. 5 A balloon at the tip of endovascular catheter (arrow)
filled with MR contrast medium (a), and CT contrast medium
(b), used for sizing ASD under MR (a), and X-ray fluoroscopy
(b). Note the close estimate of the waist (arrows), representing
the ASD diameter
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between infarct scar, border-zone and the risk of
monomorphic ventricular tachycardia [144, 154,
155]. Dong et al. found that 3D MR imaging is
helpful for tailoring ablations to the variant pulmon-
ary vein anatomy in 47% of patients with atrial
fibrilation [156]. They also noted that 3D images of
the atria helped in localizing areas along the tissue
ridge separating the left atrium from the pulmonary
vein [156, 157]. The ability of MR fluoroscopy to
visualize the needle tip in the inferior vena cava,
atria, fossa ovalis, and surrounding vasculature
during transseptal cardiac punctures has also been
demonstrated [158–161].
Atrial septal defect (ASD) is another congenital
defect common in children, leading to heart failure
and pulmonary hypertension. Percutaneous transcath-
eter delivery of an ASD occluder has been performed
on X-ray fluoroscopy [162]. A recent study showed
that MR imaging provides reliable diagnosis of ASD
[163]. Substantial experience has been obtained in
animal models where MR fluoroscopy was used for
delivery of ASD closure [164, 165] and sizing of the
ASD (Fig. 6) [166]. The ASD occluders, delivered on
MR fluoroscopy, are made of a nitenol mesh to
reduce the artifacts [161]. Others used a commercial
nitinol snare coaxial catheter system for delivering
septal occluders [166]. Schalla et al. [161] simulated
clinical-grade pediatric diagnostic catheterization in
an animal model of ASD. The advancement of the
delivery system through the IVC to the right atrium
was monitored under MR fluoroscopy (Fig. 7). In
another study, they advanced an active catheter,
under MR fluoroscopy, to right and left sides of the
heart and invasively measured pressure and oxygen in
both right and left sides of the heart [70, 161]
(Figs. 7, 8). Measurements of flow from velocity
encoded MR imaging and blood pressure from the
catheter were used to calculate pulmonary resistance.
The flow and resistance data obtained from Fick and
MR cardiac catheterization methods were in agree-
ment [70, 161], suggesting accurate physiologic data
can be obtained on MR imaging.
Fig. 6 Simulation of deployment of the septal occluder device
in vitro (a, b), and corresponding selected real-time MR
images in vivo (c, d). The device was easily detected as a
signal void on real time MR images. The closure device was
advanced inside the delivery sheath until the folded first disk
appeared (c) followed by the release of the second disk in the
right atrium (d)
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A recent study in 10 patients and 5 volunteers
showed that MR fluoroscopy is suited to guide flow
directed catheters for measurement of invasive
pulmonary artery pressures [167]. Pulmonary vas-
cular flow was noninvasively measured using veloc-
ity-encoded cine MR imaging, while pulmonary
pressure was measured invasively through a catheter
guided into the pulmonary artery under MR-guid-
ance. The results indicate that MR imaging is a
promising tool for measurement of pulmonary
vascular resistance in patients with different degrees
and forms of pulmonary hypertension. MR fluoros-
copy has also been used in connecting cardiac
chambers and blood vessels in a swine model, where
Arepally et al. connected the right and left atrium by
puncturing the interatrial septum using an active
Brockenbrough-style needle [168]. In a clinical
study in seven patients, Dick et al. conducted
Fig. 7 Catheterization of main pulmonary artery under MR-guidance. Image planes: inferior vena cava (a), right ventricular outflow
tract (b), and outflow-tract– pulmonary artery (c) and a pulmonary artery pressure curve in mm Hg (d)
Fig. 8 Selected MR fluoroscopy images show antegrade catheterization of LV (femoral venous/transseptal access). The images
show advancement of tracking catheter from RA (a), transseptally into LA (b), and LV (c). Catheter tip is detected as a cross
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trans-septal puncture and balloon septostomy under
MR fluoroscopy [169].
MR guided delivery of genes and stem cells
Vascular and cardiac disease is a major public and
economic health problem leading to more than
7 million deaths world wide each year. Current
treatments of this disease include pharmaceutical
drugs, deployment of devices and interventional
therapies. These method, however were unable to
replace necrotic, apoptotic cells and damaged vessels
by new cardiomyocytes or blood vessels. Clinical
studies confirmed that there are an increasing number
of patients who have persistent chronic angina,
despite having multiple coronary revascularization
procedures. Heart transplantation is the definitive
therapy for these patients, but this option is limited to
*2,000 donor hearts annually. Thus, there is a
mandate for alternative treatment and minimally
invasive approaches, such as endovascular catheter-
based techniques, for local delivery of new therapies
to restore cardiomyocytes and blood vessels. Angio-
genic growth factor, gene and stem cell therapy have
been recently used as an alternative treatment to
restore cardiomyocytes and blood vessels in end stage
patients, in combination with coronary artery bypass
grafting [170–175]. Recent preclinical and clinical
studies showed that percutaneous intramyocardial
and intraarterial delivery of therapies is possible
[176–180], but Hou et al. found that 11, 2.6 and 3.2%
of the delivered cells are retained in the myocardium
after intramyocardial, intracoronary, and interstitial
retrograde coronary venous delivery [181].
Local delivery approaches include surgical and
catheter-based delivery of various types of angio-
genic proteins, genes and stem cells. Open-chest
surgery, however, is impractical in end-stage patients
because this strategy increases morbidity and mor-
tality as well as limiting the feasibility of repeat
administration [182]. The advantages of catheter-
based local delivery of therapies are: (1) targeting
only the diseased region, (2) delivering a high local
dose, (3) eliminating a high systemic dose and side
effects and (4) reducing the chance of angiogenesis in
hidden tumor sites especially in elderly patients
[170–175, 183].
Gene therapy is a new approach for treating
ischemic heart disease and it is an exciting area of
modern medicine. Recent MR-guided studies dem-
onstrated the success of catheter-based transendocar-
dial delivery of genes (Fig. 2). Preclinical studies
have indicated that MR imaging provides quantitative
data on infarct size, infarct transmurality, microvas-
cular obstruction and hemorrhage). These capabilities
have positioned MR imaging as an important
approach to persue for assessing the benefits of
locally delivered genes [20]. The MR-guided
approach for delivering plasmid-VEGF gene has
been validated using histopathology as a gold stan-
dard, which ensured the efficacy of delivered therapy
into infarcted myocardium by demonstrating the
formation of new blood vessels in treated animals
(Fig. 9). Another MR study showed the increase in
collateral blood flow of infarcted myocardium after
delivering vascular endothelial growth factor [184].
Post et al. [185] demonstrated an improvement in
regional radial strain after intramyocardial injection
of adenovirus coding for P39 gene. Furthermore, Liu
et al. found a significant improvement in LV ejection
fraction and smaller number of segments with wall
motion abnormality after intramyocardial injection of
fibroblast growth factor [186].
Stem cell transplantation is another approach for
treating ischemic heart disease as it improves cardiac
function and revascularizes ischemic myocardium.
The therapeutic effect of stem cells seems to be
related to the release of angiogenic factors rather than
trans-differentiation of delivered stem cells. Two
predominant routes for stem cell delivery to infarcted
myocardium are intracoronary infusion and direct
intramyocardial injection. Each of these delivery
routes attempts to maximize the retention of deliv-
ered cells to infarcted myocardium namely. Early
clinical studies indicated that cell transplantation,
delivered under MR fluoroscopy, is safe and feasible
[97, 187–189]. MR imaging has been used not only to
track stem cells in the myocardium, but also to non-
invasively evaluate ventricular function, perfusion
and viability [190]. Cell tracking on MR imaging is
based on labeling injected cells with US FDA
approved super paramagnetic iron oxide particles
[189, 191]. It has been shown that iron labeled cells
maintain their viability, proliferation and differenti-
ation [97]. The cluster of iron labeled cells appear
dark on T2* and T2 MR images [189, 191, 192].
Several factors affect the detection of labeled cells,
which include the (1) magnetic field, (2) labeling
126 Int J Cardiovasc Imaging (2012) 28:117–137
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efficiency, (3) type of cells and (4) time of imaging
after delivery. Investigators found that the duration of
MR detection varies between cells; up to 5 weeks for
embolic stem cells [193] and up to 16 weeks for
skeletal myoblasts [194]. Investigators also found
hypo-intense tiny regions far from the site of
injection, indicative of migration of stem cells within
the infarction several weeks after delivery. MR
imaging was used to evaluate changes in LV
remodeling following the delivery of cellular therapy
[98, 195–199]. Amado et al. [200] were able to
identify a time-dependent recovery of local contrac-
tility associated with the appearance of new tissue
resulting from transplantation of allogeneic stem cells
in a pig model of myocardial infarct.
Recent randomized clinical trials demonstrated the
safety of bone marrow mononuclear treatment after
intracoronary injection [201, 202]. Promising clinical
results from intracoronary delivery of autologous
bone marrow derived stem cells and progenitor cells
showed improved myocardial function [201, 203–
206]. The proposed mechanisms of protection by
stem cells include angiogenesis via the release of
angiogenic factors, myogenesis, cytoprotection via
the release of paracrine factors, recruitment of stem
cells and suppression of inflammation [207]. More
recent 5 year follow-up studies showed that cell
therapy causes no significant improvement in LV
ejection fraction compared to placebo [208, 209].
Major limitations of intracoronary delivery include:
(1) no delivery access to infarct related to permanent
coronary artery occlusion; (2) inadequate cellular
migration into the interstitial space during the first
pass transit; (3) microembolization [210]; (4) sys-
temic delivery to non-cardiac tissue [211] and (5)
possibility of intimal dissection [212]. It has been
shown that approximately 2% of intracoronary
delivered bone marrow mononuclear cells were
retained by infarcted myocardium in humans, but
when the investigators used enriched bone marrow
Fig. 9 Photomicrographs of representative infarctions in
control (a, b) and VEGF gene–treated animals (c, d). Sections
a and c were stained with Masson trichrome stain, while b and
d were stained with biotinylated isolectin B4. Sections a and
c show chronic infarction (I) in both groups which is comprised
of homogeneous replacement fibrosis with a distinct boundary
at the interface between scar and viable myocardium (M).
Treated animal contained numerous vessels c, d) (arrows),
while control infarction contained very few vessels. Biotinyl-
ated isolectin B4 localized vessels with brown reaction
product, accentuating the neovascularity in VEGF gene–treated
infarct (d) as compared with infarct in control animal (b).
Calibration bars = 80 lm
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mononuclear cells the retention increased to 14–39%
[213].
Ripa et al. [214] used MR imaging to monitor the
changes in LV function after subcutaneous granulo-
cytes colony stimulating factor (G-CSF) injection in
patients with ST-elevated infarct. They found that
G-CSF caused no improvement in LV function.
Investigators used different types of cells, such as
progenitor cells, myocytes, adipocytes, fibroblasts, and
smooth muscle cells, in patients with ischemic heart
disease [202, 203, 214–223]. Three randomized con-
trolled studies have been published using bone marrow
cells for promoting angiogenesis [202, 203, 218]. In
the BOOST study 60 patients were enrolled to evaluate
the effect of intracoronary autologous bone marrow
cells after myocardial infarction [203]. MR imaging
showed a significant increase in ejection fraction from
50 to 57% in treated patients versus 51–52% in
untreated patients [203]. A more recent update from
the BOOST study found the beneficial effects of bone
marrow cells were sustained at 18 months [219].
Several complications have been reported after local
delivery of growth factor and cell therapies including
hemangioma [224], in-stent stenosis and hyperplasia
[225] as well as arrhythmia [226].
Summary
During the last decade medical imaging and mini-
mally invasive cardiovascular interventions have
made substantial progress. Improvements in temporal
resolution, tissue component characterization and
angiographic integration have allowed guidance in
complex interventional procedures. MR imaging
provides 3D datasets, excellent soft-tissue contrast,
multi-planar views, dynamic imaging in a single
imaging session and guidance of interventional
vascular and cardiac procedures. MR imaging allows
monitoring of treatment success after intervention
that is not available on X-ray fluoroscopy. These
advantages of MR imaging are complementary to its
potential advantage against the harmful effects of
X-ray guided procedures. In recent studies, balloon
dilation, stent placement, valvar replacement, atrial
septal defect closure, radiofrequency ablation and
local gene and cell delivery have been shown to be
feasible. In addition, MR-guided procedures involving
gene or stem cell therapy represent a new discipline
whose systematic development will foster minimally
invasive interventional procedures and will hasten the
identification and deployment of effective new thera-
pies for revascularization and myogenesis.
At present, cardiovascular interventions are
addressed by multimodality imaging using computed
tomography, invasive angiography and transesopha-
geal echocardiography. Whether MR is suited to
obviate the need for multimodality imaging is
currently unclear and needs to be further evaluated.
Furthermore, the availability of safe MR compatible
devices will guide future minimally invasive cardio-
vascular procedures. MR-guided percutaneous trans-
luminal angioplasty and vascular implants
placements (such as stents, vena cava filters, heart
valves) are examples of future clinical applications.
Catheter-based MR guidance enables a substan-
tially reduced level of invasiveness compared with
open-chest surgery, potentially resulting in treatment
on an outpatient basis, rapid patient recovery, elim-
inate radiation exposure and cost savings to the health
care system. It should be noted, however, that
translation of MR-guided interventions to clinical
use has been very slow due to limited availability of
MR-friendly catheters, wires, devices and financial
funding by National Institute of Health and venders.
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